329TiP KATE3: A phase III study of trastuzumab emtansine (T-DM1) in combination with atezolizumab or placebo in patients with previously treated HER2-positive and PD-L1–positive locally advanced or metastatic breast cancer
| Autor: | Loi, S., Schneeweiss, A., Song, E., Harries, M., De Laurentiis, M., Li, Y., Wiese, C., Poppe, R., Emens, L.A. |
|---|---|
| Zdroj: | In Annals of Oncology September 2021 32 Supplement 5:S509-S509 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|